APGE
Apogee Therapeutics, Inc. Common Stock
NASDAQ: APGE · HEALTHCARE · BIOTECHNOLOGY
$82.03
-3.91% today
Updated 2026-04-29
Market cap
$6.39B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.22
Dividend yield
—
52W range
$34 – $95
Volume
0.9M
Apogee Therapeutics, Inc. Common Stock (APGE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $152.06M | $401.40M | $753.95M |
| Cash & equivalents | — | — | — |
| Current assets | $152.06M | $398.41M | $529.71M |
| Total liabilities | $9.98M | $21.49M | $37.16M |
| Current liabilities | $9.98M | $20.56M | $28.56M |
| Long-term debt | — | — | — |
| Shareholder equity | — | — | — |
| Retained earnings | $-39.78M | $-123.77M | $-305.92M |
| Accounts receivable | — | $1.21M | $4.70M |
| Inventory | — | — | — |
| Goodwill | — | — | — |